Clinical trial registry record

OphtAI Diagnostic Performance Validation for Automated Screening of Eye Diseases

A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Unknown.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated September 28, 2023.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05752045
Last registry update
September 28, 2023
Status
Unknown
Phase
Phase not reported
Sponsor
Evolucare Technologies
Enrollment
1389
Countries
France
Match confidence
60%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NA · SINGLE GROUP · SCREENING · NONE
Evidence population
Human clinical study registration
Participants
1389
Population
ALL · 18 Years
Duration
2023-06-28 to 2024-03-01
Intervention
Eye Fundus Double Capture for Eye Diseases Screening with OphtAI Medical Device
Comparator
Not reported
Outcomes measured
Referable Diabetic Retinopathy screening sensitivity/specificity — 1 year; Diabetic retinopathy grading sensitivity/specificity — 1 year; Diabetic retinopathy grading + RDR-EOphtha algorithms combination sensitivity/specificity for RDR detection — 1 year; Diabetic retinopathy grading + RDR-OphDiaT_full algorithms combination sensitivity/specificity for RDR detection — 1 ye…; Diabetic retinopathy grading + RDR-EOphtha +DME algorithms combination sensitivity/specificity for RDR detection — 1 ye…; Diabetic retinopathy grading + RDR-OphDiaT_full +DME algorithms combination sensitivity/specificity for RDR detection —…; Diabetic Macular Edema algorithm sensitivity/specificityfor DME detection — 1 year; Age-Related Macular Degeneration algorithm sensitivity/specificity for AMD detection — 1 year; Age-Related Maculopathy algorithm ("drusen") sensitivity/specificity for ARM detection — 1 year; Glaucoma algorithms sensitivity/specificity for Glaucoma suspicion — 1 year; Quality algorithm accuracy for quality assessment — 1 year; Laterality determination algorithm accuracy for laterality assessment — 1 year
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 60% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Vision ageing · 60%Source terminology contains: age-related macular degeneration. Source terminology supplies longevity context: age-related. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

vision aging
Open primary sourceExport JSON